-+ 0.00%
-+ 0.00%
-+ 0.00%

10x Genomics Partners With Dana-Farber Cancer Institute For Tumor Samples From Patients With Major Solid Cancer Types

Benzinga·01/12/2026 14:11:09
Listen to the news

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Dana-Farber Cancer Institute to analyze tumor samples from patients with major solid cancer types to uncover biological features associated with treatment response, resistance and disease progression. The company also announced plans to establish a CLIA-certified laboratory. Together, these efforts mark the beginning of a multi-year research initiative to incorporate single cell and spatial tumor analysis into potential diagnostic workflows to support cancer patient care.